{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T03:50:40Z","timestamp":1772164240861,"version":"3.50.1"},"reference-count":51,"publisher":"American Association for Cancer Research (AACR)","issue":"1","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>It is generally accepted that human cancers derive from a mutated single cell. However, the genetic steps characterizing various stages of progression remain unclear. Studying a unique case of metastatic melanoma, we observed that cell lines derived from metachronous metastases arising over a decade retained a central core of genetic stability in spite of divergent phenotypes. In the present study, we expanded our previous observations comparing these autologous cell lines of clonal derivation with allogeneic ones and correlated array comparative genomic hybridization (aCGH) with gene expression profiling to determine their relative contribution to the dynamics of disease progression. aCGH and gene expression profiling were performed on autologous cell lines and allogeneic melanoma cell lines originating from other patients. A striking correlation existed between total extent of genetic imbalances, global transcriptional patterns, and cellular phenotypes. They did not follow a strict temporal progression but stemmed independently at various time points from a central core of genetic stability best explained according to the cancer stem cell hypothesis. Although their contribution was intertwined, genomic imbalances detectable by aCGH contributed only 25% of the transcriptional traits determining autologous tumor distinctiveness. Our study provides important insights about the dynamics of cancer progression and supports the development of targeted anticancer therapies aimed against stable genetic factors that are maintained throughout the end stage of disease. [Cancer Res 2008;68(1):122\u201331]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-1939","type":"journal-article","created":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T21:02:33Z","timestamp":1199307753000},"page":"122-131","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Conservation of Genetic Alterations in Recurrent Melanoma Supports the Melanoma Stem Cell Hypothesis"],"prefix":"10.1158","volume":"68","author":[{"given":"Marianna","family":"Sabatino","sequence":"first","affiliation":[{"name":"1Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G. Magnuson Clinical Center,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingdong","family":"Zhao","sequence":"additional","affiliation":[{"name":"2Biometrics Research Branch,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Voiculescu","sequence":"additional","affiliation":[{"name":"1Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G. Magnuson Clinical Center,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Monaco","sequence":"additional","affiliation":[{"name":"1Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G. Magnuson Clinical Center,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Robbins","sequence":"additional","affiliation":[{"name":"3Surgery Branch, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laszlo","family":"Karai","sequence":"additional","affiliation":[{"name":"4Pathology Department, National Cancer Institute, NIH, Bethesda, Maryland;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Nickoloff","sequence":"additional","affiliation":[{"name":"5Skin Disease Research Program, Loyola University, Chicago Medical Center, Maywood, Illinois;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Maio","sequence":"additional","affiliation":[{"name":"6Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy;"},{"name":"7Cancer Bio-Immunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Selleri","sequence":"additional","affiliation":[{"name":"1Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G. Magnuson Clinical Center,"},{"name":"8Department of Human Morphology, University of Milano, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco M.","family":"Marincola","sequence":"additional","affiliation":[{"name":"1Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G. Magnuson Clinical Center,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ena","family":"Wang","sequence":"additional","affiliation":[{"name":"1Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G. Magnuson Clinical Center,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2008,1,2]]},"reference":[{"key":"2022061623202051300_B1","doi-asserted-by":"crossref","unstructured":"Sidransky D. Screening for clonal genetic alterations. Eur J Cancer\u20081995; 31A: 1127\u20139.","DOI":"10.1016\/0959-8049(95)00167-H"},{"key":"2022061623202051300_B2","doi-asserted-by":"crossref","unstructured":"Iannaccone PM, Weinberg WC, Deamant FD. On the clonal origin of tumors: a review of experimental models. Int J Cancer\u20081987; 39: 778\u201384.","DOI":"10.1002\/ijc.2910390621"},{"key":"2022061623202051300_B3","doi-asserted-by":"crossref","unstructured":"Fang D, Nguyen TK, Leishear K, et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res\u20082005; 65: 9328\u201337.","DOI":"10.1158\/0008-5472.CAN-05-1343"},{"key":"2022061623202051300_B4","doi-asserted-by":"crossref","unstructured":"Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res\u20081998; 58: 2170\u20135.","DOI":"10.1016\/S0923-1811(98)83846-2"},{"key":"2022061623202051300_B5","doi-asserted-by":"crossref","unstructured":"Wiltshire RN, Dennis TR, Sondak VK, Meltzer PS, Trent JM. Application of molecular cytogenetic techniques in a case study of human cutaneous metastatic melanoma. Cancer Genet Cytogenet\u20082001; 131: 97\u2013103.","DOI":"10.1016\/S0165-4608(01)00539-8"},{"key":"2022061623202051300_B6","doi-asserted-by":"crossref","unstructured":"Balazs M, Adam Z, Treszl A, Begany A, Hunyadi J, Adany R. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry\u20082001; 46: 222\u201332.","DOI":"10.1002\/cyto.1131"},{"key":"2022061623202051300_B7","doi-asserted-by":"crossref","unstructured":"Wang E, Voiculescu S, Le Poole IC, et al. Clonal persistence and evolution during a decade of recurrent melanoma. J Invest Dermatol\u20082006; 126: 1372\u20137.","DOI":"10.1038\/sj.jid.5700193"},{"key":"2022061623202051300_B8","doi-asserted-by":"crossref","unstructured":"Rasheed S, Mao Z, Chan JM, Chan LS. Is melanoma a stem cell tumor? Identification of neurogenic proteins in trans-differentiated cells. J Transl Med\u20082005; 3: 14.","DOI":"10.1186\/1479-5876-3-14"},{"key":"2022061623202051300_B9","doi-asserted-by":"crossref","unstructured":"Grichnik JM, Burch JA, Schulteis RD, et al. Melanoma, a tumor based on a mutant stem cell? J Invest Dermatol\u20082006; 126: 142\u201353.","DOI":"10.1038\/sj.jid.5700017"},{"key":"2022061623202051300_B10","doi-asserted-by":"crossref","unstructured":"Grichnik JM. Genomic instability and tumor stem cells. J Invest Dermatol\u20082006; 126: 1214\u20136.","DOI":"10.1038\/sj.jid.5700240"},{"key":"2022061623202051300_B11","doi-asserted-by":"crossref","unstructured":"Rubinfeld B, Robbins P, el Gamil M, Albert I, PorfiriE, Polakis P. Stabilization of \u03b2-catenin by genetic defects in melanoma cell lines. Science\u20081997; 275: 1790\u20132.","DOI":"10.1126\/science.275.5307.1790"},{"key":"2022061623202051300_B12","doi-asserted-by":"crossref","unstructured":"Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature\u20082005; 434: 843\u201350.","DOI":"10.1038\/nature03319"},{"key":"2022061623202051300_B13","doi-asserted-by":"crossref","unstructured":"Nelson MA, Radmacher MD, Simon R, et al. Chromosome abnormalities in malignant melanoma: clinical significance of nonrandom chromosome abnormalities in 206 cases. Cancer Genet Cytogenet\u20082000; 122: 101\u20139.","DOI":"10.1016\/S0165-4608(00)00281-8"},{"key":"2022061623202051300_B14","unstructured":"Roschke AV, Tonon G, Gehlhaus KS, et al. Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res\u20082003; 63: 8634\u201347."},{"key":"2022061623202051300_B15","doi-asserted-by":"crossref","unstructured":"Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med\u20082005; 353: 2135\u201347.","DOI":"10.1056\/NEJMoa050092"},{"key":"2022061623202051300_B16","unstructured":"Hyman E, Kauraniemi P, Hautaniemi S, et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res\u20082002; 62: 6240\u20135."},{"key":"2022061623202051300_B17","doi-asserted-by":"crossref","unstructured":"Pollack JR, Sorlie T, Perou CM, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A\u20082002; 99: 12963\u20138.","DOI":"10.1073\/pnas.162471999"},{"key":"2022061623202051300_B18","doi-asserted-by":"crossref","unstructured":"Furge KA, Dykema KJ, Ho C, Chen X. Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma. BMC Genomics\u20082005; 6: 67.","DOI":"10.1186\/1471-2164-6-67"},{"key":"2022061623202051300_B19","doi-asserted-by":"crossref","unstructured":"Nigro JM, Misra A, Zhang L, et al. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res\u20082005; 65: 1678\u201386.","DOI":"10.1158\/0008-5472.CAN-04-2921"},{"key":"2022061623202051300_B20","doi-asserted-by":"crossref","unstructured":"Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet\u20082005; 37 Suppl: S11\u20137.","DOI":"10.1038\/ng1569"},{"key":"2022061623202051300_B21","unstructured":"Macville M, Schrock E, Padilla-Nash H, et al. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res\u20081999; 59: 141\u201350."},{"key":"2022061623202051300_B22","doi-asserted-by":"crossref","unstructured":"Masramon L, Ribas M, Cifuentes P, et al. Cytogenetic characterization of two colon cell lines by using conventional G-banding, comparative genomic hybridization, and whole chromosome painting. Cancer Genet Cytogenet\u20082000; 121: 17\u201321.","DOI":"10.1016\/S0165-4608(00)00219-3"},{"key":"2022061623202051300_B23","doi-asserted-by":"crossref","unstructured":"Roschke AV, Stover K, Tonon G, Schaffer AA, Kirsch IR. Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability. Neoplasia\u20082002; 4: 19\u201331.","DOI":"10.1038\/sj.neo.7900197"},{"key":"2022061623202051300_B24","doi-asserted-by":"crossref","unstructured":"Kawai K, Viars C, Arden K, Tarin D, Urquidi V, Goodison S. Comprehensive karyotyping of the HT-29 colon adenocarcinoma cell line. Genes Chromosomes Cancer\u20082002; 34: 1\u20138.","DOI":"10.1002\/gcc.10003"},{"key":"2022061623202051300_B25","doi-asserted-by":"crossref","unstructured":"Vogl A, Sartorius U, Vogt T, et al. Gene expression profile changes between melanoma metastases and their daughter cell lines: implication for vaccination protocols. J Invest Dermatol\u20082005; 124: 401\u20134.","DOI":"10.1111\/j.0022-202X.2004.23603.x"},{"key":"2022061623202051300_B26","doi-asserted-by":"crossref","unstructured":"Jin P, Zhao Y, Ngalame Y, et al. Selection and validation of endogenous reference genes using a high throughput approach. BMC Genomics\u20082004; 5: 55.","DOI":"10.1186\/1471-2164-5-55"},{"key":"2022061623202051300_B27","doi-asserted-by":"crossref","unstructured":"Wang E. RNA amplification for successful gene profiling analysis. J Transl Med\u20082005; 3: 28.","DOI":"10.1186\/1479-5876-3-28"},{"key":"2022061623202051300_B28","doi-asserted-by":"crossref","unstructured":"Cormier JN, Panelli MC, Hackett JA, et al. Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model. Int J Cancer\u20081999; 80: 781\u201390.","DOI":"10.1002\/(SICI)1097-0215(19990301)80:5<781::AID-IJC24>3.0.CO;2-A"},{"key":"2022061623202051300_B29","doi-asserted-by":"crossref","unstructured":"Adams SD, Barracchini KC, Chen D, et al. Ambiguous allele combinations in HLA class I and class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification. J Transl Med\u20082004; 2: 30.","DOI":"10.1186\/1479-5876-2-30"},{"key":"2022061623202051300_B30","doi-asserted-by":"crossref","unstructured":"Adams S, Robbins FM, Chen D, et al. HLA class I and II genotype of the NCI-60 cell lines. J Transl Med\u20082005; 3: 11.","DOI":"10.1186\/1479-5876-3-11"},{"key":"2022061623202051300_B31","unstructured":"Lieu PT, Jozsi P, Gilles P, Peterson T. Development of a DNA-labeling system for array-based comparative genomic hybridization. J Biomol Tech\u20082005; 16: 104\u201311."},{"key":"2022061623202051300_B32","doi-asserted-by":"crossref","unstructured":"Wang E, Miller L, Ohnmacht GA, Liu E, Marincola FM. High fidelity mRNA amplification for gene profiling using cDNA microarrays. Nat Biotechnol\u20082000; 17: 457\u20139.","DOI":"10.1038\/74546"},{"key":"2022061623202051300_B33","doi-asserted-by":"crossref","unstructured":"Feldman AL, Costouros NG, Wang E, et al. Advantages of mRNA amplification for microarray analysis. Biotechniques\u20082002; 33: 906\u201314.","DOI":"10.2144\/02334mt04"},{"key":"2022061623202051300_B34","doi-asserted-by":"crossref","unstructured":"Balazs M, Carroll P, Kerschmann R, Sauter G, Waldman FM. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization. Genes Chromosomes Cancer\u20081997; 19: 84\u20139.","DOI":"10.1002\/(SICI)1098-2264(199706)19:2<84::AID-GCC3>3.0.CO;2-W"},{"key":"2022061623202051300_B35","doi-asserted-by":"crossref","unstructured":"Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi OP. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer\u20081998; 21: 177\u201384.","DOI":"10.1002\/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.0.CO;2-X"},{"key":"2022061623202051300_B36","doi-asserted-by":"crossref","unstructured":"Urzua U, Frankenberger C, Gangi L, Mayer S, Burkett S, Munroe DJ. Microarray comparative genomic hybridization profile of a murine model for epithelial ovarian cancer reveals genomic imbalances resembling human ovarian carcinomas. Tumour Biol\u20082005; 26: 236\u201344.","DOI":"10.1159\/000087378"},{"key":"2022061623202051300_B37","doi-asserted-by":"crossref","unstructured":"Gargalovic PS, Imura M, Zhang B, et al. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc Natl Acad Sci U S A\u20082006; 103: 12741\u20136.","DOI":"10.1073\/pnas.0605457103"},{"key":"2022061623202051300_B38","doi-asserted-by":"crossref","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A\u20082005; 102: 15545\u201350.","DOI":"10.1073\/pnas.0506580102"},{"key":"2022061623202051300_B39","doi-asserted-by":"crossref","unstructured":"Cormier JN, Hijazi YM, Abati A, et al. Heterogeneous expression of melanoma-associated antigens (MAA) and HLA-A2 in metastatic melanoma in vivo. Int J Cancer\u20081998; 75: 517\u201324.","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<517::AID-IJC5>3.0.CO;2-W"},{"key":"2022061623202051300_B40","doi-asserted-by":"crossref","unstructured":"Wang Z, Marincola FM, Rivoltini L, Parmiani G, Ferrone S. Selective human leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells. J Exp Med\u20081999; 190: 205\u201315.","DOI":"10.1084\/jem.190.2.205"},{"key":"2022061623202051300_B41","doi-asserted-by":"crossref","unstructured":"Ohta M, Berd D, Shimizu M, et al. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma. Int J Cancer\u20081996; 65: 762\u20137.","DOI":"10.1002\/(SICI)1097-0215(19960315)65:6<762::AID-IJC9>3.0.CO;2-X"},{"key":"2022061623202051300_B42","doi-asserted-by":"crossref","unstructured":"Gursky S, Olopade OI, Rowley JD. Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types. Cancer Genet Cytogenet\u20082001; 129: 93\u2013101.","DOI":"10.1016\/S0165-4608(01)00444-7"},{"key":"2022061623202051300_B43","doi-asserted-by":"crossref","unstructured":"Mandruzzato S, Callegaro A, Turcatel G, et al. A gene expression signature associated with survival in metastatic melanoma. J Transl Med\u20082006; 4: 50.","DOI":"10.1186\/1479-5876-4-50"},{"key":"2022061623202051300_B44","doi-asserted-by":"crossref","unstructured":"Wang E, Panelli MC, Zavaglia K, et al. Melanoma-restricted genes. J Transl Med\u20082004; 2: 34.","DOI":"10.1186\/1479-5876-2-34"},{"key":"2022061623202051300_B45","doi-asserted-by":"crossref","unstructured":"Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet\u20081993; 9: 138\u201341.","DOI":"10.1016\/0168-9525(93)90209-Z"},{"key":"2022061623202051300_B46","unstructured":"Brose MS, Volpe P, Feldman M, et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res\u20082002; 62: 6997\u20137000."},{"key":"2022061623202051300_B47","unstructured":"Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature\u20082002; 417: 949\u201354."},{"key":"2022061623202051300_B48","doi-asserted-by":"crossref","unstructured":"Pirker C, Holzmann K, Spiegl-Kreinecker S, et al. Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes. Melanoma Res\u20082003; 13: 483\u201392.","DOI":"10.1097\/00008390-200310000-00007"},{"key":"2022061623202051300_B49","doi-asserted-by":"crossref","unstructured":"Garraway LA, Widlund HR, Rubin MA, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature\u20082005; 436: 117\u201322.","DOI":"10.1038\/nature03664"},{"key":"2022061623202051300_B50","doi-asserted-by":"crossref","unstructured":"Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today\u20081995; 16: 487\u201394.","DOI":"10.1016\/0167-5699(95)80033-6"},{"key":"2022061623202051300_B51","doi-asserted-by":"crossref","unstructured":"Marincola FM, Jaffe EM, Hicklin DJ, Ferrone S. Escape of human solid tumors from T cell recognition: molecular mechanisms and functional significance. Adv Immunol\u20082000; 74: 181\u2013273.","DOI":"10.1016\/S0065-2776(08)60911-6"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/1\/122\/2591110\/122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/1\/122\/2591110\/122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T01:37:12Z","timestamp":1737769032000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/1\/122\/540544\/Conservation-of-Genetic-Alterations-in-Recurrent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,1,2]]},"published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-1939","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22370099.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370096.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370096","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22370099","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6496265.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6496265","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}